Literature DB >> 3687590

Identification and quantitation of PAF from psoriatic scales.

C S Ramesha1, N Soter, W C Pickett.   

Abstract

Platelet activating factor was isolated from scales of psoriatic patients by the procedure of Bligh and Dyer and purified by silica gel thin layer chromatography. The purified PAF was digested with phospholipase C and the resulting diglyceride was derivatized into PFB ethers. The PAF-PFB ethers were analyzed using fused silica capillary chromatography-negative ion chemical ionization mass spectrometry. Different molecular species of PAF were identified by their negative ion mass spectra and by their elution time from the capillary column. All the molecular species had high abdundance (greater than 90%) of the molecular anion. 1-0-Hexadecyl-2-acetyl-GPC (16:0) was the major PAF species representing 51% of the total PAF. 17:0 and 18:1 were the next abundant species representing 15 and 16%, respectively. Several minor PAF molecular species were also present. The amount of each PAF molecular species was quantitated from 1-0-hexadecyl-2-2H3 acetyl-GPC used as the internal standard. Nanogram quantities of PAF were recovered from 100 mg of psoriatic scales. Significant amounts of lysoPAF were also present in these scales. The alkyl chain of the lysoPAF was compared with that of PAF.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3687590     DOI: 10.1007/bf01966522

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  6 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

Review 2.  Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids.

Authors:  F Snyder
Journal:  Med Res Rev       Date:  1985 Jan-Mar       Impact factor: 12.944

3.  Structural identification of platelet activating factor in psoriatic scale.

Authors:  A I Mallet; F M Cunningham
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

4.  Rapid isocratic high-performance liquid chromatographic purification of platelet activating factor (PAF) and lyso-PAF from human skin.

Authors:  A I Mallet; F M Cunningham; R Daniel
Journal:  J Chromatogr       Date:  1984-07-13

5.  Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid.

Authors:  C S Ramesha; W C Pickett
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

6.  Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry.

Authors:  C S Ramesha; W C Pickett
Journal:  Biomed Environ Mass Spectrom       Date:  1986-03
  6 in total
  2 in total

1.  Platelet-activating factor blockade inhibits the T-helper type 17 cell pathway and suppresses psoriasis-like skin disease in K5.hTGF-β1 transgenic mice.

Authors:  Tej Pratap Singh; Barbara Huettner; Harald Koefeler; Gerlinde Mayer; Isabella Bambach; Katrin Wallbrecht; Michael P Schön; Peter Wolf
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Platelet activating factor (PAF) and lyso-PAF in psoriasis.

Authors:  M R Judge; R M Barr; A I Mallet; F Courtney; A Kobza Black; M W Greaves
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.